dipyrone and Disease Exacerbation

dipyrone has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mateus, JE; Silva, CD; Teles, C; Vaio, T1
Hayashi, Y; Hirose, N; Katare, RG; Lee, GH; Maeda, H; Radhakrishnan, G; Rao, P; Sasaguri, S; Yamaguchi, T; Yamamoto, M1

Other Studies

2 other study(ies) available for dipyrone and Disease Exacerbation

ArticleYear
Acute intermittent porphyria: analgesia can be dangerous.
    BMJ case reports, 2019, Sep-30, Volume: 12, Issue:9

    Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Dipyrone; Disease Progression; Female; Glucose; Hemin; Humans; Hyponatremia; Infusions, Parenteral; Middle Aged; Muscle Weakness; Pain Management; Porphyria, Acute Intermittent; Treatment Outcome

2019
Bilirubin oxidation provoked by nitric oxide radicals predicts the progression of acute cardiac allograft rejection.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2007, Volume: 7, Issue:8

    Topics: Acute Disease; Animals; Bilirubin; Biomarkers; Blotting, Western; Dipyrone; Disease Models, Animal; Disease Progression; Free Radical Scavengers; Graft Rejection; Heart Transplantation; Heme Oxygenase-1; Immunohistochemistry; Myocardium; Nitric Oxide; Oxidation-Reduction; Prognosis; Rats; Transplantation, Homologous; Tyrosine

2007